Intercure Ltd. Ordinary Shares
INCR
Closed
$0.95
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
InterCure Ltd. engages in the provision of business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.
Country
IL
CEO
Mr. Alexander Rabinovitch
IPO date
2007
Employees
320
ISIN
IL0011063760
Website
Key stats
Open
$0.98
Volume
3.77K
Market cap
$60.16M
Prev. close
$0.98
Impl / hst vl
-
Open interest
$0.00
$0.95
Day’s Range
$0.98
$0.72
52W Range
$1.23
Valuation
50
Valuation score
Fairly Valued
P/E
-
P/S
0.32
P/B
0.40
Current ratio
1.85
Debt / Equity
0.20
ROE
-11.63%
Gross margin
30.47%
Income growth
-1,368.87%
FCF growth
-
Analysts estimates
Consensus rating
Buy
The average rating from top 4 analysts indicates that stock is expected to perform in line with the market
Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$0.02
The top 3 analysts forecasts that 12-month price may decrease by 97.83%, with a low of $0.02 and a high of $0.02
$0.02
Low
$0.02
Avg
$0.02
High
Current price
Earnings
Q4 ‘23 revenue
$118.49M
Q4 ‘23 net income
-$20.65M
Revenue
Net income
Previous EPS
-Estimate EPS
$0.07
Actual EPS
Estimate EPS
Explore the Healthcare sector
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply